Abstract
Various therapy modalities have been proposed as standard treatments in management of bone metastases. Radiation therapy remains the standard of care for patients with localized bone pain, but up to 30% of them do not experience notable pain relief. Percutaneous cryoablation is a minimally invasive technique that induces necrosis by alternately freezing and thawing a target tissue. This technique is successfully used to treat a variety of malignant and benign diseases in different sites. 18F-FDG positron emission tomography/computed tomography (18F-FDG PET/CT) is a single technique of imaging that provides in a “single step” both morphological and metabolic features of neoplastic lesions of the bone. The aim of this study was to evaluate the efficacy of the cryosurgical technique on secondary musculoskeletal masses according to semi-quantitative PET analysis and clinical-test evaluation with the visual analogue scale (VAS). We enrolled 20 patients with painful bone lesions (score pain that exceeded 4 on the VAS) that were non-responsive to treatment; one lesion per patient was treated. All patients underwent a PET-CT evaluation before and 8 weeks after cryotherapy; maximum standardized uptake value (SUVmax) was measured before and after treatment for metabolic assessment of response to therapy. After treatment, 18 patients (90%) showed considerable reduction in SUVmax value (>50%) suggestive of response to treatment; only 2 patients did not show meaningful reduction in metabolic activity. Our preliminary study demonstrates that quantitative analysis provided by PET correlates with response to cryoablation therapy as assessed by CT data and clinical VAS evaluation.
Similar content being viewed by others
References
Nielsen OS, Munro AJ, Tannock IF, et al. Bone metastases: pathophysiology and management policy. J Clin Oncol. 1991;9:509–24.
Mercante S. Malignant bone pain: pathophysiology and treatment. Pain. 1997;69:1–18.
Hage WD, Aboulafia AJ, Aboulafia DM, et al. Incidence, location, and diagnostic evaluation of metastatic bone disease. Orthop Clin N Am. 2000;31:515–28.
Price P, Hoskin PJ, Easton D, et al. Prospective randomized trial of single and multifraction radiotherapy schedules in the treatment of painful bone metastases. Radio Ther Oncol. 1986;6:247–55.
Poullsen HS, Nielsen OS, Klee M, et al. Palliative radiotherapy in the treatment of skeletal metastasis. Eur J Pain. 1989;6:323–30.
Gangi A, Kastler B, Klinkert A, Dietemann JL. Injection of alcohol into bone metastases under CT guidance. J Comput Assist Tomogr. 1994;18:932–5.
Gröenemeyer DH, Schirp S, Gevargez A. Image-guided percutaneous thermal ablation of bone tumors. Acad Radiol. 2002;9:467–77.
Simon CJ, Dupuy DE, William W. Microwave ablation: principles and applications. Radiographics. 2005;25:69–83.
Callstrom MR, Charboneau JW, Goetz MP, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol. 2004;22:300–6.
Callstrom MR, Atwell TD, Charboneau W, et al. Painful metastases involving bone: percutaneous Image-guided cryoablation—prospective trial interim analysis. Radiology. 2006;241:572–80.
Orlacchio A, Bazzocchi G, Pastorelli D, et al. Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience. Cardiovasc Intervent Radiol. 2008;31:587–94.
Xu KC, Niu LZ, He WB, et al. Percutaneous cryosurgery for the treatment of hepatic colorectal metastases. World J Gastroenterol. 2008;14:1430–6.
Davol PE, Fulmer BR, Rukstalis DB. Long-term results of cryoablation for renal cancer and complex renal masses. Urology. 2006;68(Suppl 1A):2–6.
Kaufman CS, Bachman B, Littrup P, et al. Office-based ultrasound-guided cryoablation of breast fibroadenomas. Am J Surg. 2002;184:394–400.
Witzsch UK, Skriapas K, Becht E. Cryoablation of prostate cancer. Urologe. 2008;47:449–54.
Specht JM, Tam SL, Kurland BF, Gralow JR, et al. Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP). Breast Cancer Res Treat. 2007;105:87–94.
Gwak HS, Youn SM, Chang U, et al. Usefulness of (18)F-fluorodeoxyglucose PET for radiosurgery planning and response monitoring in patients with recurrent spinal metastasis. Minim Invasive Neurosurg. 2006;49:127–34.
Orlacchio A, Schillaci O, Antonelli L, et al. Solitary pulmonary nodules: morphological and metabolic characterization by FDG-PET-MDCT. Radiol Med. 2007;112:157–73.
Phillips M, Allen C, Gerson P, McClain K. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2009;52:97–101.
Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS. Accuracy of fluorodeoxyglucose-positron emission tomography for diagnosis of single bone metastasis: comparison with bone scintigraphy. J Comput Assist Tomogr. 2007;31:812–19.
Tong D, Gillick L, Hendrickson FR. The palliation of symptomatic osseous metastases: final results of the study by the Radiation Therapy Oncology Group. Cancer. 1982;50:893–9.
McQuay H, Collins S, Carroll D, Moore R. Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev. 3:CD001793
Steenland E, Leer JW, van Houwelingen H, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol. 1999;52:101–9.
Masala S, Manenti G, Roselli M, et al. Percutaneous combined therapy for painful sternal metastases: a radiofrequency thermal ablation (RFTA) and cementoplasty protocol. Anticancer Res. 2007;27:4259–62.
Stafford SE, Gralow JR, Schubert EK, et al. Use of serial FDG PET to measure the response of bone dominant breast cancer to therapy. Acad Radiol. 2002;9:913–21.
Conflict of interest
The authors declare they have no financial relationship with the organization that sponsored the research and also that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Masala, S., Schillaci, O., Bartolucci, A.D. et al. Metabolic and clinical assessment of efficacy of cryoablation therapy on skeletal masses by 18F-FDG positron emission tomography/computed tomography (PET/CT) and visual analogue scale (VAS): initial experience. Skeletal Radiol 40, 159–165 (2011). https://doi.org/10.1007/s00256-010-0960-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-010-0960-y